Schedule 13D ownership disclosure

Anacor Pharmaceuticals Inc

Security class unavailable · CUSIP: 032420101

Event date: 2015-08-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,171,374
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000903423-15-000522
Form type
SC 13D/A
Filer
Anacor Pharmaceuticals, Inc.
CIK
CIK 1411158
Filed
Aug 14, 2015
Reporting period
Aug 13, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub